Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn Sells 1,311 Shares

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 1,311 shares of Phreesia stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71. Following the completion of the transaction, the senior vice president now directly owns 115,633 shares in the company, valued at approximately $3,076,994.13. The trade was a 1.12 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Stock Up 5.3 %

NYSE:PHR opened at $28.42 on Thursday. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.16. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of -19.33 and a beta of 0.94. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock’s 50 day moving average price is $22.50 and its two-hundred day moving average price is $22.53.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period in the previous year, the company earned ($0.58) earnings per share. Equities research analysts expect that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Phreesia

A number of institutional investors and hedge funds have recently modified their holdings of the company. International Assets Investment Management LLC grew its holdings in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Phreesia in the second quarter valued at approximately $202,000. Point72 DIFC Ltd bought a new position in shares of Phreesia during the 2nd quarter worth approximately $209,000. XTX Topco Ltd acquired a new position in shares of Phreesia during the 3rd quarter worth approximately $247,000. Finally, Hsbc Holdings PLC acquired a new position in shares of Phreesia during the 2nd quarter worth approximately $301,000. 92.10% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. KeyCorp upped their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday. Robert W. Baird reduced their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. JMP Securities reissued a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Truist Financial boosted their target price on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a research note on Wednesday. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $30.64.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.